Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

41.30
Delayed Data
As of Jul 22
 +0.27 / +0.66%
Today’s Change
21.19
Today|||52-Week Range
60.79
-23.22%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close41.03
Today’s open41.05
Day’s range40.52 - 41.38
Volume264,789
Average volume (3 months)460,475
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-8.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...-0.18-0.34%
HCMHutchison China Medi...-0.07-0.54%
TXMDTherapeuticsMD Inc-0.20-2.51%
IRWDIronwood Pharmaceuti...+0.43+3.11%
Data as of 4:00pm ET, 07/22/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs